Characteristics and treatment options of glucagonomas: a national study from the French Group of Endocrine Tumors and ENDOCAN-RENATEN network
CONCLUSION: Patients with glucagonoma had prolonged survival, even in the presence of metastases at diagnosis. Curative-intent surgery should always be considered. Chemotherapy, PRRT or liver-directed therapy seem to provide both substantial antitumor and antisecretory efficacy.PMID:38039101 | DOI:10.1093/ejendo/lvad157
Source: European Journal of Endocrinology - Category: Endocrinology Authors: Marine Perrier Mathias Brugel Laura G érard Bernard Goichot Astrid Li èvre Come Lepage Vincent Hautefeuille Christine Do Cao Denis Smith Philippe Thuillier J érôme Cros Guillaume Cadiot Thomas Walter Louis de Mestier Source Type: research
More News: Brain | Chemotherapy | Diabetes | Endocrinology | France Health | Liver | Neurology | Neurosurgery | Pancreas | Study | Urology & Nephrology | Weight Loss